Seer Inc
Change company Symbol lookup
Select an option...
SEER Seer Inc
ITCI Intra-Cellular Therapies Inc
VZ Verizon Communications Inc
TISI Team Inc
PRTK Paratek Pharmaceuticals Inc
KIRY Kiewit Royalty Trust
OCAXW OCA Acquisition Equity Warrant Exp 14 Jan 2026 *W EXP 01/31/2028
ABBV Abbvie Inc
IIIN Insteel Industries Inc
KO Coca-Cola Co
Go

Company profile

Seer, Inc. is a life sciences technology company. The Company enables scientific outcomes by commercializing products for researchers to unlock biological information. Its initial product, the Proteograph Product Suite (Proteograph), uses its engineered nanoparticle (NP) technology to provide access across the proteome. Its Proteograph Product Suite is comprised of consumables, an automation instrument and software. Its Proteograph provides a workflow, which enables proteomic profiling and the analysis of samples needed to characterize the nature of the proteome. The Company’s Proteograph consumables consist of its NP panel and other consumables necessary to assay samples on its SP100 automation instrument. Its SP100 automation instrument is custom-configured liquid handling workstation. The Company's Proteograph Instrument Control Software (PICS) for the SP100 instrument is fixed and designed to its specified workflow.

Closing Price
$25.17
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
517,492
0

Nvidia's pending Arm merger faces heightened regulatory scrutiny as competitive concerns mount

10:23 am ET November 16, 2021 (MarketWatch)
Print

By Emily Bary

The U.K. will conduct an in-depth investigation of the pending deal after initially determining the combination could impede competition

Nvidia Corp.'s deal for Arm Ltd. faces additional regulatory scrutiny after its was referred for additional investigation in the U.K.

Digital Secretary Nadine Dorries asked the U.K's Competition and Markets Authority (CMA) to conduct an "in-depth" Phase Two investigation of the deal, according to a press release issued on the U.K. government's website Tuesday. The CMA has 24 weeks to complete its investigation, which is looking into concerns about the proposed merger on "competition and national security grounds."

The CMA already conducted a Phase One investigation, which determined that the proposed deal "raises the possibility of a 'substantial lessening of competition across four key markets,' -- data centres, Internet of Things, the automotive sector and gaming applications," per the release.

Nvidia (NVDA) announced in September 2020 that it planned to acquire Arm from Softbank Corp. in a deal valued at $40 billion. At the time, analysts thought the deal had the potential to expand Nvidia's dominance, though they predicted that the merger would face regulatory pushback in various markets.

Regulators in the E.U. also launched a recent in-depth investigation into the pending combination.

"Whilst Arm and Nvidia do not directly compete, Arm's IP is an important input in products competing with those of Nvidia, for example in [data centers], automotive and in Internet of Things," European Commission Executive Vice-President Margrethe Vestager said in a late-October release announcing the opening of the E.U.'s in-depth investigation. "Our analysis shows that the acquisition of Arm by Nvidia could lead to restricted or degraded access to Arm's IP, with distortive effects in many markets where semiconductors are used."

Nvidia shares are off 0.5% in Tuesday's session, but they've been on a hot streak recently, rising 37% over the past month as the S&P 500 has gained 5%. The company is due to report earnings Wednesday afternoon.

-Emily Bary

	

(END) Dow Jones Newswires

November 16, 2021 10:23 ET (15:23 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.